FAKTOR-OPTIONSSCHEIN - DIASORIN Stock

DE000MG156H4

Real-time Bid/Ask 04:26:47 2024-06-03 EDT
15.47 ^EUR / 15.53 ^EUR	+2.51%

1 month

+16.31%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Funds move on Banco BPM, DiaSorin and Webuild.	05-30	AN
Futures bearish; focus on European data	05-30	AN
Stock markets in the red; DiaSorin snap on Mib.	05-29	AN
Indices flat; Newlat runs after Princes acquisition.	05-27	AN

More news

Quotes 5-day view

Date	Price	Change
24-06-03	15.5	+2.51%
24-05-31	15.12	-6.61%
24-05-30	16.19	+7.57%
24-05-29	15.05	-0.40%
24-05-28	15.11	+0.27%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 04:20 am

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	DIASORIN S.P.A.
Issuer	Morgan Stanley
WKN	MG156H
ISIN	DE000MG156H4
Date issued	2024-03-27
Strike	75.5 €
Maturity	Unlimited
Parity	1.56 : 1
Emission price	10 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	17.7 €
Lowest since issue	8.2 €
Spread	0.06 €
Spread %	0.39%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

98.94 EUR

Average target price

100.1 EUR

Spread / Average Target

+1.15%

Consensus